Summit's SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data - GlobeNewswire https://t.co/V12GT8BImr

Summit's SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical Data - GlobeNewswire https://t.co/V12GT8BImr

— IDRO (@IDROOhio) February 25, 2019

from Twitter https://twitter.com/IDROOhio

February 25, 2019 at 02:13AM